: Specific mechanisms of how the reactive microenvironment affects prostate cancer progression are? unknown. Previous studies from our group have shown that the reactive microenvironment has properties? and gene expression similar to wound repair biology. These include changes in stromal cell phenotype,? altered neurogenesis and the involvement of specific T regulatory cells. We have also shown that reactive? stroma is tumor promoting. These studies have shown that carcinoma cells and nerves exhibit reciprocal? interactions leading to elevated carcinoma proliferation and induced neurogenesis. In addition, the? involvement of gamma-sigma T regulatory cells may play an important role in tumor progression. The concurrent? recruitment of myofibroblasts to PIN and carcinoma foci implicates a coordinated host response in these? biologies that promotes tumorigenesis. Importantly, our group has shown that specific biomarkers of this? reactive microenvironment are predictive of recurrence of human prostate cancer. The integrated biologies? of this response and specific mechanisms are not yet understood at a level where more effective prognostics? or novel therapeutics can be developed. Accordingly, the overall objectives of this project are to understand? how reactive stroma, neurogenesis, and immunity responses in prostate cancer microenvironment function? and interact mechanistically during the initiation and progression of early, organ confined disease. The? endpoint of this study is to understand the key components, regulators, and mechanisms with a specific? focus on early prostate cancer. We have assembled a team of experts who will focus their efforts on? understanding three interrelated biologies in the tumor microenvironment. We propose a Program? composed of an Expression Analysis and Pathology Core and three interrelated Projects. Project 1 will? address the co-evolution, origin, and specific regulators of reactive stromal cells. Project .2 will address the? role of axonogenesis and neurogenesis in regulating early cancer. Project 3 will focus on the role of gamma-sigma T? regulatory cells and signaling through Toll-like receptors in prostate cancer progression. Together, these? Projects and Core will provide fundamental data regarding the temporal and spatial composition, gene? expression profiling, and potential regulators of the microenvironment in human tissues and mouse models.? This group of Investigators has worked together for several years and has planned these studies around? their pre-established collaborations. The overall goal of this Program is to provide novel pre-clinical data,? from which more effective biomarkers and therapeutics can be developed that target the microenvironment? of early prostate cancer.? PERFORMANCE SITE(S) (organization, city, state)? Baylor College of Medicine? Houston Texas? PHS 398 (Rev. 04/06) Page 2 Form Page 2? Principal Investigator/Program Director (Last, First, Middle): Rowley, David R., Ph.D.? KEY PERSONNEL. See instructions. Use continuation pages as needed to provide the required information in the format shown below.? Start with Principal Investigator(s). List all other key personnel in alphabetical order, last name first.? Name? Rowley, David R,? Rowley, David R.? Abd-EI-Fatta, ElMoataz? Ayala, Gustavo E.? Ayala, Gustavo E.? Chen, Wenhao (July, 2006)? Dai, Hong? Hilsenbeck, Susan G.? Hong, Jun (July 2006)? Ittman, Michael M.? Ittman, Michael M.? eRA Commons User Name? DROWLEY? DROWLEY? GAYALA? GAYALA? Shilsenbeck? Ittmann? Ittmann? Organization? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Baylor College of Med.? Role on Project? Principal Investigator? Project Leader, P1? Research Associate, P2? Project Leader, P2? CORE Co-Leader? Postdoctoral Fellow, P3? Research Associate, P2? Co-Investigator, CORE? Postdoctoral Fellow, P3? CORE Leader? Collaborator, P2? OTHER SIGNIFICANT CONTRIBUTORS? Name? NA? Organization Role on Project

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA126568-02
Application #
7289833
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (O1))
Program Officer
Mohla, Suresh
Project Start
2006-09-25
Project End
2011-08-31
Budget Start
2007-09-04
Budget End
2008-08-31
Support Year
2
Fiscal Year
2007
Total Cost
$700,401
Indirect Cost
Name
Baylor College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Coarfa, Christian; Florentin, Diego; Putluri, NagiReddy et al. (2018) Influence of the neural microenvironment on prostate cancer. Prostate 78:128-139
He, Dandan; Manzoni, Adriana; Florentin, Diego et al. (2016) Biologic effect of neurogenesis in pancreatic cancer. Hum Pathol 52:182-9
Farach, Andrew; Ding, Yi; Lee, MinJae et al. (2016) Neuronal Trans-Differentiation in Prostate Cancer Cells. Prostate 76:1312-25
San Martin, Rebeca; Barron, David A; Tuxhorn, Jennifer A et al. (2014) Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis. Am J Pathol 184:1860-70
Dakhova, Olga; Rowley, David; Ittmann, Michael (2014) Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo. Clin Cancer Res 20:100-9
Olar, Adriana; He, Dandan; Florentin, Diego et al. (2014) Biological correlates of prostate cancer perineural invasion diameter. Hum Pathol 45:1365-9
Olar, Adriana; He, Dandan; Florentin, Diego et al. (2014) Biologic correlates and significance of axonogenesis in prostate cancer. Hum Pathol 45:1358-64
Ding, Yi; He, Dandan; Florentin, Diego et al. (2013) Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res 19:6101-11
Ayala, Gustavo; Morello, Matteo; Frolov, Anna et al. (2013) Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol 231:77-87
Creighton, Chad J (2012) Molecular classification and drug response prediction in cancer. Curr Drug Targets 13:1488-94

Showing the most recent 10 out of 22 publications